ReviewFrontiers in oncology2021
Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer.
Priyanka Hirani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it